Search

Search Constraints

You searched for: Author/Creator Forster, M.

Search Results

3. Phase I study of lurbinectedin (PM01183) in combination with cisplatin (CDDP) with or without aprepitant in patients (pts) with advanced solid tumors. (February 2017)

4. Novel biomarker-driven trial of a cell and gene therapy for the treatment of malignant pleural mesothelioma (MPM): the STRATEGIC trial. (January 2020)

5. 316 Phase I study of lurbinectedin (PM01183) in combination with cisplatin (C) with or without aprepitant (Ap) in patients (pts) with advanced solid tumors. (September 2015)

6. 3112 Nintedanib in combination with cisplatin/gemcitabine as 1st-line therapy for advanced squamous non-small cell lung cancer. (September 2015)